Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Integra LifeSciences Holdings Corp buy melinda

Start price
€53.24
29.08.18 / 50%
Target price
€55.92
06.09.18
Performance (%)
5.47%
End price
€56.15
06.09.18
Summary
This prediction ended on 06.09.18 with a price of €56.15. With a performance of 5.47%, the BUY prediction by melinda for Integra LifeSciences Holdings Corp closed with a slight gain. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Integra LifeSciences Holdings Corp 1.515% 1.515% -41.228% -56.066%
iShares Core DAX® -0.922% -1.078% 12.165% 16.796%
iShares Nasdaq 100 0.371% -0.556% 38.622% 49.370%
iShares Nikkei 225® 2.224% -2.825% 19.015% 4.643%
iShares S&P 500 -0.026% -0.788% 28.485% 42.479%

Comments by melinda for this prediction

In the thread Integra LifeSciences Holdings Corp diskutieren
Prediction Buy
Perf. (%) 5.47%
Target price 55.924
Change
Ends at 06.09.18

SecteurEquipement, fournitures et distribution médicale Agenda 06/09 | 14:35 Présentation



Métier
Logo Integra Lifesciences Holdi
Develops, manufactures and markets medical devices, implants and biomaterials

Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment.

It operates through the Codman Specialty Surgical and Orthopedics and Tissue Technologies segments.

The Codman Specialty Surgical segment includes neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices.

The Orthopedics and Tissue Technologies segment comprises offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair.

The company was founded by Richard E. Caruso in 1989 and is headquartered in Plainsboro, NJ.

Nombre d'employés : 4 400 personnes.



Prediction Buy
Perf. (%) 5.47%
Target price 55.924
Change
Ends at 06.09.18

(Zielkurs erreicht)

Stopped prediction by melinda for Integra LifeSciences Holdings Corp

buy
Integra LifeSciences Holdings Corp

Start price
Target price
Perf. (%)
€44.40
26.10.22
€48.00
26.10.23
-24.77%
26.10.23

buy
Integra LifeSciences Holdings Corp

Start price
Target price
Perf. (%)
€45.33
28.09.17
€49.61
05.02.18
5.07%
05.02.18

buy
Integra LifeSciences Holdings Corp

Start price
Target price
Perf. (%)
€48.26
07.07.17
€49.16
12.07.17
1.87%
12.07.17